Observational Study of Outcomes in Cystic Fibrosis Patients With Selected Gating Mutations on a CFTR Allele (The VOCAL Study)
NCT02445053
·
clinicaltrials.gov ↗
COMPLETED
Status
75
Enrollment
INDUSTRY
Sponsor class
Conditions
Cystic Fibrosis
Interventions
DRUG:
ivacaftor
Sponsor
Vertex Pharmaceuticals Incorporated